Rhythm Biosciences

(ASX) RHY

Current Price$0.14

Market Cap$50.97M

Since IPO (2017)-51%

5 Year-86%

1 Year+150%

1 Month-28%

Rhythm Biosciences Financials at a Glance

Market Cap

$50.97M

Revenue (TTM)

$5.66M

Net Income (TTM)

$8.85M

EPS (TTM)

$-0.02

P/E Ratio

-6.28

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Price

$0.14

Volume

286,575

Open

$0.15

Price

$0.14

Volume

286,575

Open

$0.15

Previous Close

$0.14

Daily Range

$0.14 - $0.15

52-Week Range

$0.05 - $0.28

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Price

$0.14

Volume

286,575

Open

$0.15

Previous Close

$0.14

Daily Range

$0.14 - $0.15

52-Week Range

$0.05 - $0.28

RHY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rhythm Biosciences

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

David George Atkins, PhD, MBA

Website

www.rhythmbio.com

Headquarters

Parkville, VIC 3010, AU

RHY Financials

Key Financial Metrics (TTM)

Gross Margin

-64%

Operating Margin

-112%

Net Income Margin

-94%

Return on Equity

-190%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-15.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$50.97M

Shares Outstanding

364.06M

Volume

286.57K

Avg. Volume

862.95K

Financials (TTM)

Gross Profit

$2.97M

Operating Income

$3.53M

EBITDA

$3.53M

Operating Cash Flow

$2.92M

Capital Expenditure

$23.21K

Free Cash Flow

$2.94M

Cash & ST Invst.

$1.48M

Total Debt

$1.11M

Rhythm Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$46.25K

-97.3%

Gross Profit

$2.14M

+16.7%

Gross Margin

-46.24%

N/A

Market Cap

$50.97M

N/A

Market Cap/Employee

$2.22M

N/A

Employees

N/A

Net Income

$2.26M

+44.8%

EBITDA

$3.69M

+34.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$1.47M

+19.8%

Accounts Receivable

$61.39K

-19.8%

Inventory

$73.29K

+1687.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$262.44K

+237.0%

Return on Assets

-2.15%

N/A

Return on Invested Capital

-3.70%

N/A

Free Cash Flow

$2.22M

+29.0%

Operating Cash Flow

$2.22M

+27.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MAP.AXMicroba Life Sciences Limited

MAP.AXMicroba Life Sciences Limited$0.08+8.57%

HMD.AXHeraMED Limited

HMD.AXHeraMED Limited$0.05+6.52%

IIQ.AXINOVIQ Ltd

IIQ.AXINOVIQ Ltd$0.33+0.00%

BDX.AXBCAL Diagnostics Limited

BDX.AXBCAL Diagnostics Limited$0.08+0.00%

NOX.AXNoxopharm Limited

NOX.AXNoxopharm Limited$0.07+7.14%

AT1.AXAtomo Diagnostics Limited

AT1.AXAtomo Diagnostics Limited$0.02+0.00%

IDT.AXIDT Australia Limited

IDT.AXIDT Australia Limited$0.04+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About RHY

What is the current price of Rhythm Biosciences?

Rhythm Biosciences is trading at A$0.14 per share.

What is the 52-week range for Rhythm Biosciences?

Over the past 52 weeks, Rhythm Biosciences has traded between A$0.05 and A$0.28.

How much debt does Rhythm Biosciences have?

As of the most recent reporting period, Rhythm Biosciences reported total debt of $1.11M.

How much cash does Rhythm Biosciences have on hand?

Rhythm Biosciences reported $1.40M in cash and cash equivalents in its most recent financial results.

What is Rhythm Biosciences’s dividend yield?

Rhythm Biosciences does not currently have a dividend yield.

Rhythm Biosciences

Rhythm Biosciences Financials at a Glance

RHY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rhythm Biosciences

RHY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rhythm Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RHY

What is the current price of Rhythm Biosciences?

What is the 52-week range for Rhythm Biosciences?

How much debt does Rhythm Biosciences have?

How much cash does Rhythm Biosciences have on hand?

What is Rhythm Biosciences’s dividend yield?

Premium Investing Services